Form 8-K - Current report:
SEC Accession No. 0001144204-12-000937
Filing Date
2012-01-06
Accepted
2012-01-06 12:32:28
Documents
6
Period of Report
2011-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v244879_8k.htm 8-K 36828
2 EXHIBIT 10.01 v244879_ex10-01.htm EX-10.01 328428
3 EXHIBIT 10.02 v244879_ex10-02.htm EX-10.02 57472
4 EXHIBIT 10.03 v244879_ex10-03.htm EX-10.03 57735
5 EXHIBIT 10.04 v244879_ex10-04.htm EX-10.04 57604
6 EXHIBIT 99.1 v244879_ex99-1.htm EX-99.1 11588
  Complete submission text file 0001144204-12-000937.txt   550725
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

EIN.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30975 | Film No.: 12513742
SIC: 3826 Laboratory Analytical Instruments